World & BusinessIchor Biologics reportedly seeks $80–100 million in minority stake sale
The Economic Times reports that the Hyderabad-based maker of therapeutic proteins derived from human plasma is seeking private equity funding.
TLDR
Ichor Biologics is seeking $80–100 million from private equity investors through a minority stake sale, The Economic Times reports. The company specializes in plasma-based therapies, manufacturing therapeutic protein products derived from human plasma.
Ichor Biologics reportedly seeks $80–100 million in minority stake sale
The Economic Times reports that the Hyderabad-based maker of therapeutic proteins derived from human plasma is seeking private equity funding.
TLDR
Ichor Biologics is seeking $80–100 million from private equity investors through a minority stake sale, The Economic Times reports. The company specializes in plasma-based therapies, manufacturing therapeutic protein products derived from human plasma.